AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
PHASE-I STUDY OF THE DUOCARMYCIN SEMISYNTHETIC DERIVATIVE KW-2189 GIVEN DAILY FOR 5 DAYS EVERY 6 WEEKS
Authors: ALBERTS SR ERLICHMAN C REID JM SLOAN JA AMES MM RICHARDSON RL GOLDBERG RM
Citation: Sr. Alberts et al., PHASE-I STUDY OF THE DUOCARMYCIN SEMISYNTHETIC DERIVATIVE KW-2189 GIVEN DAILY FOR 5 DAYS EVERY 6 WEEKS, Clinical cancer research, 4(9), 1998, pp. 2111-2117
CLINICAL AND PHARMACOKINETIC (PK) RESULTS OF 4 PHASE-I STUDIES OF THE2ND-GENERATION MATRIX METALLOPROTEASE (MMP) INHIBITOR BAY-12-9566, A NONPEPTIDIC BIPHENYL INHIBITOR OF MMPS-2, MMPS-3 AND MMPS-9
Authors: SEYMOUR L GROCHOW L ECKHARDT G ERLICHMAN C HIRTE H GOEL R HUMPHREY R ELIAS I
Citation: L. Seymour et al., CLINICAL AND PHARMACOKINETIC (PK) RESULTS OF 4 PHASE-I STUDIES OF THE2ND-GENERATION MATRIX METALLOPROTEASE (MMP) INHIBITOR BAY-12-9566, A NONPEPTIDIC BIPHENYL INHIBITOR OF MMPS-2, MMPS-3 AND MMPS-9, Annals of oncology, 9, 1998, pp. 601-601
INTERACTIONS OF OXALIPLATIN WITH THE TOPOISOMERASE-I INHIBITORS TOPOTECAN AND SN-38
Authors: ERLICHMAN C BOERNER S KAUFMANN SH
Citation: C. Erlichman et al., INTERACTIONS OF OXALIPLATIN WITH THE TOPOISOMERASE-I INHIBITORS TOPOTECAN AND SN-38, Annals of oncology, 9, 1998, pp. 225-225
A PHASE-I STUDY OF BIZELESIN (NSC-615291) IN SOLID TUMORS
Authors: RAYSON D PITOT HC REID JM AMES MM BAGNIEWSKI PG ERLICHMAN C SLOAN JA ADJEI AA
Citation: D. Rayson et al., A PHASE-I STUDY OF BIZELESIN (NSC-615291) IN SOLID TUMORS, Annals of oncology, 9, 1998, pp. 475-475
SYNERGISTIC CYTOTOXICITY OF MTA (LY231514) AND GEMCITABINE IN-VITRO AND IN-VIVO
Authors: ADJEI AA ERLICHMAN C THORNTON D ALBERTS SR SLOAN JA GOLDBERG RM PITOT H REID J
Citation: Aa. Adjei et al., SYNERGISTIC CYTOTOXICITY OF MTA (LY231514) AND GEMCITABINE IN-VITRO AND IN-VIVO, Annals of oncology, 9, 1998, pp. 644-644
IRINOTECAN PLUS 5-FU AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER - NORTH-AMERICAN TRIALS
Authors: GOLDBERG RM ERLICHMAN C
Citation: Rm. Goldberg et C. Erlichman, IRINOTECAN PLUS 5-FU AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER - NORTH-AMERICAN TRIALS, Oncology, 12(8), 1998, pp. 59-63
TOXICITY OF FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - EFFECT OF ADMINISTRATION SCHEDULE AND PROGNOSTIC FACTORS
Authors: LEVY E PIEDBOIS P BUYSE M PIGNON JP ROUGIER P RYAN L HANSEN R ZEE B WEINERMAN B PATER J LEICHMAN C MACDONALD J BENEDETTI J LOKICH J FRYER J BRUFMAN G ISACSON R LAPLANCHE A QUINAUX E THIRION P RYAN L HANSEN R HARRINGTON D MCFADDEN E RIBBLE A JACOBSON R ZEE B WEINERMAN B PATER J LEICHMAN C MACDONALD J BENEDETTI J LOKICH J FRYER J PIGNON JP LAPLANCHE A LUBOINSKI M ROUGIER P BRUFMAN G ISACSON R VAITKEVICIUS V PIEDBOIS P LEBOURGEOIS JP PIEDBOIS Y GAUTHIER E LEVY E THIRION P DURANDZALENSKI I BUYSE M QUINAUX E WOLMARK N PIEDBOIS P BUYSE M CARLSON R RUSTUM Y ERLICHMAN C
Citation: E. Levy et al., TOXICITY OF FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - EFFECT OF ADMINISTRATION SCHEDULE AND PROGNOSTIC FACTORS, Journal of clinical oncology, 16(11), 1998, pp. 3537-3541
PROSPECTIVELY RANDOMIZED TRIAL OF POSTOPERATIVE ADJUVANT CHEMOTHERAPYIN PATIENTS WITH HIGH-RISK COLON-CANCER
Authors: OCONNELL MJ LAURIE JA KAHN M FITZGIBBONS RJ ERLICHMAN C SHEPHERD L MOERTEL CG KOCHA WI PAZDUR R WIEAND HS RUBIN J VUKOV AM DONOHUE JH KROOK JE FIGUEREDO A
Citation: Mj. Oconnell et al., PROSPECTIVELY RANDOMIZED TRIAL OF POSTOPERATIVE ADJUVANT CHEMOTHERAPYIN PATIENTS WITH HIGH-RISK COLON-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 295-300
EFFICACY OF INTRAVENOUS CONTINUOUS-INFUSION OF FLUOROURACIL COMPARED WITH BOLUS ADMINISTRATION IN ADVANCED COLORECTAL-CANCER
Authors: WOLMARK N PIEDBOIS P ROUGIER P BUYSE M PIGNON JP RYAN L HANSEN R ZEE B WEINERMAN B PATER J LEICHMAN C MACDONALD J BENEDETTI J LOKICH J FRYER J BRUFMAN G ISACSON R LAPLANCHE A LEVY E HARRINGTON D MCFADDEN E RIBBLE A JACOBSON R LUBOINSKI M VAITKEVICIUS V LEBOURGEOIS JP PIEDBOIS Y GAUTHIER E DURANDZALESKI I CARLSON R RUSTUM Y ERLICHMAN C
Citation: N. Wolmark et al., EFFICACY OF INTRAVENOUS CONTINUOUS-INFUSION OF FLUOROURACIL COMPARED WITH BOLUS ADMINISTRATION IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 301-308
EFFECT OF ADDING THE TOPOISOMERASE-I POISON 7-ETHYL-10-HYDROXYCAMPTOTHECIN (SN-38) TO 5-FLUOROURACIL AND FOLINIC ACID IN HCT-8 CELLS - ELEVATED DTTP POOLS AND ENHANCED CYTOTOXICITY
Authors: MULLANY S SVINGEN PA KAUFMANN SH ERLICHMAN C
Citation: S. Mullany et al., EFFECT OF ADDING THE TOPOISOMERASE-I POISON 7-ETHYL-10-HYDROXYCAMPTOTHECIN (SN-38) TO 5-FLUOROURACIL AND FOLINIC ACID IN HCT-8 CELLS - ELEVATED DTTP POOLS AND ENHANCED CYTOTOXICITY, Cancer chemotherapy and pharmacology, 42(5), 1998, pp. 391-399
THE SEARCH FOR CYTOTOXIC SYNERGY - AN IN-VITRO AND CLINICAL-STUDY OF PYRAZOLOACRIDINE (PZA) AND CARBOPLATIN (CBDCA) IN SOLID TUMORS
Authors: ADJEI AA KAUFMANN SH ALBERTS SR GOLDBERG RM REID J SLOAN JA ERLICHMAN C
Citation: Aa. Adjei et al., THE SEARCH FOR CYTOTOXIC SYNERGY - AN IN-VITRO AND CLINICAL-STUDY OF PYRAZOLOACRIDINE (PZA) AND CARBOPLATIN (CBDCA) IN SOLID TUMORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 5246-5246
MOLECULAR MARKERS IN MALE BREAST-CARCINOMA
Authors: RAYSON D ERLICHMAN C SUMAN VJ ROCHE PC WOLD LE INGLE JN DONOHUE JH
Citation: D. Rayson et al., MOLECULAR MARKERS IN MALE BREAST-CARCINOMA, Cancer, 83(9), 1998, pp. 1947-1955
PHASE-I AND PHARMACOLOGICAL TRIAL OF FAZARABINE (ARA-AC) WITH GRANULOCYTE COLONY-STIMULATIAG FACTOR
Authors: GOLDBERG RM REID JM AMES MM SLOAN JA RUBIN J ERLICHMAN C KUFFEL MJ FITCH TR
Citation: Rm. Goldberg et al., PHASE-I AND PHARMACOLOGICAL TRIAL OF FAZARABINE (ARA-AC) WITH GRANULOCYTE COLONY-STIMULATIAG FACTOR, Clinical cancer research, 3(12), 1997, pp. 2363-2370
EVALUATION OF CONTINUOUS-INFUSION SURAMIN IN METASTATIC BREAST-CANCER- IMPACT ON PLASMA-LEVELS OF INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-BINDING PROTEINS
Authors: LAWRENCE JB CONOVER CA HADDAD TC INGLE JN REID JM AMES MM SUMAN VJ MARKS RS ERLICHMAN C HARTMANN LC
Citation: Jb. Lawrence et al., EVALUATION OF CONTINUOUS-INFUSION SURAMIN IN METASTATIC BREAST-CANCER- IMPACT ON PLASMA-LEVELS OF INSULIN-LIKE GROWTH-FACTORS (IGFS) AND IGF-BINDING PROTEINS, Clinical cancer research, 3(10), 1997, pp. 1713-1720
AN EVALUATION OF POSTOPERATIVE FOLLOW-UP TESTS IN COLON-CANCER PATIENTS TREATED FOR CURE
Authors: PEETHAMBARAM P WEISS M LOPRINZI CL NOVOTNY P OFALLON JR ERLICHMAN C OCONNELL MJ LAURIE JA
Citation: P. Peethambaram et al., AN EVALUATION OF POSTOPERATIVE FOLLOW-UP TESTS IN COLON-CANCER PATIENTS TREATED FOR CURE, Oncology, 54(4), 1997, pp. 287-292
OPTIMAL DURATION OF FLUOROURACIL PLUS LEVAMISOLE COLON-CANCER SURGICAL ADJUVANT THERAPY
Authors: OCONNELL MJ KAHN MJ ERLICHMAN C GOLDBERG RM SHEPHERD LE
Citation: Mj. Oconnell et al., OPTIMAL DURATION OF FLUOROURACIL PLUS LEVAMISOLE COLON-CANCER SURGICAL ADJUVANT THERAPY, Journal of clinical oncology, 14(10), 1996, pp. 2887-2887
A PHASE-I STUDY OF COMBINED RADIATION-THERAPY WITH 5-FLUOROURACIL ANDLOW-DOSE FOLINIC ACID IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC ORBILIARY CARCINOMA (VOL 34, PG 445, 1996)
Authors: HSUE V WONG CS MOORE M ERLICHMAN C CUMMINGS BJ MACLEOD M
Citation: V. Hsue et al., A PHASE-I STUDY OF COMBINED RADIATION-THERAPY WITH 5-FLUOROURACIL ANDLOW-DOSE FOLINIC ACID IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC ORBILIARY CARCINOMA (VOL 34, PG 445, 1996), International journal of radiation oncology, biology, physics, 35(1), 1996, pp. 203-203
A PHASE-I STUDY OF COMBINED RADIATION-THERAPY WITH 5-FLUOROURACIL ANDLOW-DOSE FOLINIC ACID IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC ORBILIARY CARCINOMA
Authors: HSUE V WONG CS MOORE M ERLICHMAN C CUMMINGS BJ MACLEOD M
Citation: V. Hsue et al., A PHASE-I STUDY OF COMBINED RADIATION-THERAPY WITH 5-FLUOROURACIL ANDLOW-DOSE FOLINIC ACID IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC ORBILIARY CARCINOMA, International journal of radiation oncology, biology, physics, 34(2), 1996, pp. 445-450
A PHASE-II TRIAL OF 5-FLUOROURACIL AND 1-LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: ERLICHMAN C FINE S KERR I HOFFMANN W GORG C SCHMOLL HJ PREUSSER P THUERLIMANN B GUSTAVSSON B
Citation: C. Erlichman et al., A PHASE-II TRIAL OF 5-FLUOROURACIL AND 1-LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, American journal of clinical oncology, 19(1), 1996, pp. 26-31
MALE BREAST-CANCER - AN 11 YEAR REVIEW OF 66 PATIENTS
Authors: MCLACHLAN SA ERLICHMAN C LIU FF MILLER N PINTILIE M
Citation: Sa. Mclachlan et al., MALE BREAST-CANCER - AN 11 YEAR REVIEW OF 66 PATIENTS, Breast cancer research and treatment, 40(3), 1996, pp. 225-230
A CLINICAL AND PHARMACOLOGICAL STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND INTERFERON-ALFA IN ADVANCED COLORECTAL-CANCER
Authors: MOORE MJ KAIZER L ERLICHMAN C MYERS R FELD R THIESSEN JJ FINE S
Citation: Mj. Moore et al., A CLINICAL AND PHARMACOLOGICAL STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND INTERFERON-ALFA IN ADVANCED COLORECTAL-CANCER, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 86-90
CYTOTOXIC AND BIOCHEMICAL IMPLICATIONS COMBINING AZT AND AG-331
Authors: PRESSACCO J MITROVSKI B ERLICHMAN C
Citation: J. Pressacco et al., CYTOTOXIC AND BIOCHEMICAL IMPLICATIONS COMBINING AZT AND AG-331, Cancer chemotherapy and pharmacology, 35(5), 1995, pp. 387-390
EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER
Authors: LABIANCA R MARSONI S PANCERA G TORRI V ZANIBONI A ERLICHMAN C PATER J SHEPHERD L ZEE B SEITZ JF MILAN C PIGNON JP AITINI E APOLONE G AUZZANI A BANDUCCI S BARNI S BERETTA GD BIFFI O BUCCI F CARDI G CIFATTE D COLUCCI G COMANDONE A COMELLA G CONFALONIERI C CONFU A COSTANZO M CRESPI C DAMIANI E DEGIORGI D DONGIOVANNI V FABRIS G FABRIZIO G FACENDOLA G FANTONI PA FERRAGNI A FIORI B FLORIANELLO F FRONTINI L GALLI E GARATTINI P GHERARDI G GIOVANELLI A GUILIANI F GOSSO P JANNIELLO GP KILDANI B LEO S LIBERATI A MAFFIONE G MAIELLO E MAIORINO L MANENTE P MARTIGNONI GC MARZOLA M MASTRODONATO M MERIGGI F MOLINARI B MOLINARI GF MONFERRONI N NASCIMBEN O NATALE C NEGRETTI S PALAZZO S PANVINI D PARISI V PEDICINI T PERADOTTO F PESSA S PIATTO E PIZZI G PROSPERI A PRUSCIANO F RABBI C RAINA A RUGGIERO A SAVA C SCANZI F CARRARO PS SMERIERI F STIVALA B TAIANA A TARDIO B TESTORE F TINAZZI A TURCATO G ZONATO S AYOUB J BELANGER K BIRON G BODURTHA AJ BOOS G BURNELL M CANO P CHARPENTIER D CHOW WSW CHRITCHLEY J CRIPPS C DANG SP DAVIS ML DAVIDSON M DINGLE B DRYER D FERLAND E FIELDS A FINE S JOLIVET J KAISER L KERR I KOCHA WI KOTWALL C KRIEGER H LEPINEMARTIN M LITTLE C LOFTERS WS MAHEU M MOORE M PRESSNAIL B RAGAZ J RAUNER H REZNICK R ROSS T ROTSTEIN L RUDINSKAS L SCHACTER B SHAH A SKILLINGS J STERN H TWEEDDALE M VANDENBERG T WALDE D WATT HJ WONG KWA YOSHIDA S BALDIT C BARONI JL BAZIN JP BEDENNE L BLANCHI A BOGNEL JC BOSSET JF BOUCHE O BRANDONE JM BRICOT R BURTIN P CADOR L CHARBIT M CHARLIER A COUROUBLE Y COUZIGOU P CUILLERET J DELPERO JR DUCREUX M DUMAS F ECHINARD E ETIENNE PL FRIGUET JL GIGNOUX M GIOVANNINI M HERR JP LAFON J LETREUT P LATRIVE JP LAUVAUX C LOUVET C MACKIEWICZ R MAUREL C MESSERSCHMITT C MORAND L MOREAU J MORIN T NORDLINGER B NOTERDAEME PM OLLIER JC PICAUD R PEINKOWSKI P PLACHOT JP PORTET R DUBATY HR ROUGIER P ROZENTAL G SASTRE B VOTTELAMBERT A WATRIN B ZEITOUN P
Citation: R. Labianca et al., EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER, Lancet, 345(8955), 1995, pp. 939-944
EFFECTS OF THYMIDYLATE SYNTHASE INHIBITION ON THYMIDINE KINASE-ACTIVITY AND NUCLEOSIDE TRANSPORTER EXPRESSION
Authors: PRESSACCO J MITROVSKI B ERLICHMAN C HEDLEY DW
Citation: J. Pressacco et al., EFFECTS OF THYMIDYLATE SYNTHASE INHIBITION ON THYMIDINE KINASE-ACTIVITY AND NUCLEOSIDE TRANSPORTER EXPRESSION, Cancer research, 55(7), 1995, pp. 1505-1508
MODULATION OF THE EQUILIBRATIVE NUCLEOSIDE TRANSPORTER BY INHIBITORS OF DNA-SYNTHESIS
Authors: PRESSACCO J WILEY JS JAMIESON GP ERLICHMAN C HEDLEY DW
Citation: J. Pressacco et al., MODULATION OF THE EQUILIBRATIVE NUCLEOSIDE TRANSPORTER BY INHIBITORS OF DNA-SYNTHESIS, British Journal of Cancer, 72(4), 1995, pp. 939-942
Risultati: 1-25 | 26-36